Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith M Sullivan

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
Transplantation and Cellular Therapy|February 1, 2026
Academic Career Success: Love, Family and Research SkillsKeith M Sullivan
International Journal of Hematology|November 15, 2002
Bone marrow transplantation for non-malignant diseaseKeith M Sullivan
Transplantation and Cellular Therapy|September 26, 2024
Toward a Cure for Autoimmune DiseasesKeith M Sullivan
Transplantation and Cellular Therapy|January 19, 2026
Getting it Right: Standard in Marrow Transplant and Cellular TherapyKeith M Sullivan
Transplantation and Cellular Therapy|July 3, 2023
Caring for Our Patients, Their Loved Ones and Each OtherKeith M Sullivan
Transplantation and Cellular Therapy|February 26, 2026
Getting it Right: Standards in Marrow Transplant and Cellular TherapyKeith M Sullivan
Seminars in Arthritis and Rheumatism|March 9, 2025
Hematopoietic stem cell transplant, chimeric antigen receptor T-cells, and other cellular therapies as stepping stones toward long-term improvement in severe scleroderma and other autoimmune diseasesKeith M Sullivan
Hematology (Amsterdam, Netherlands)|June 16, 2001
Late Effects of Hematopoietic Stem Cell Transplantation; Bone Marrow TransplantationEmin Kansu, Keith M. Sullivan
Nature Reviews. Rheumatology|September 19, 2019
Allogeneic HSCT for autoimmune disease: a shared decisionKeith M Sullivan, Stefanie Sarantopoulos
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 17, 2009
Carbon monoxide diffusion capacity: how low can you go for hematopoietic cell transplantation eligibility?Jason W Chien, Keith M Sullivan
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
Transplantation and Cellular Therapy|February 1, 2026
Academic Career Success: Love, Family and Research SkillsKeith M Sullivan
International Journal of Hematology|November 15, 2002
Bone marrow transplantation for non-malignant diseaseKeith M Sullivan
Transplantation and Cellular Therapy|September 26, 2024
Toward a Cure for Autoimmune DiseasesKeith M Sullivan
Transplantation and Cellular Therapy|January 19, 2026
Getting it Right: Standard in Marrow Transplant and Cellular TherapyKeith M Sullivan
Transplantation and Cellular Therapy|July 3, 2023
Caring for Our Patients, Their Loved Ones and Each OtherKeith M Sullivan
Transplantation and Cellular Therapy|February 26, 2026
Getting it Right: Standards in Marrow Transplant and Cellular TherapyKeith M Sullivan
Seminars in Arthritis and Rheumatism|March 9, 2025
Hematopoietic stem cell transplant, chimeric antigen receptor T-cells, and other cellular therapies as stepping stones toward long-term improvement in severe scleroderma and other autoimmune diseasesKeith M Sullivan
Hematology (Amsterdam, Netherlands)|June 16, 2001
Late Effects of Hematopoietic Stem Cell Transplantation; Bone Marrow TransplantationEmin Kansu, Keith M. Sullivan
Nature Reviews. Rheumatology|September 19, 2019
Allogeneic HSCT for autoimmune disease: a shared decisionKeith M Sullivan, Stefanie Sarantopoulos
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 17, 2009
Carbon monoxide diffusion capacity: how low can you go for hematopoietic cell transplantation eligibility?Jason W Chien, Keith M Sullivan
Pageof 10